South Africa's Aspen Pharmacare has set its sights on rapid expansion in China.

A dispute over the pricing of drugs in Pakistan that has led many of the pharmaceutical manufacturers in the country to stop making tuberculosis drugs is…

Zhejiang Hisun Pharmaceuticals has won China license rights to epithelial mAb oncology early-stage candidate pritumumab from Nascent Biotech.

India’s Sun Pharma Advanced Research Company has licensed its novel epilepsy drug Elepsia XR to its parent to speed up U.S. market entry following…

Hanmi Pharmaceutical eyes branded drugs, fast-paced R&D and investment in China to get growth on track.

India's drug regulatory system--currently split between federal goals and state implementation--needs an overhaul that puts one superagency at the top.

As many as 500 drug manufacturing plants in India will be inspected head-to-toe in a phased effort to ensure good manufacturing practice compliance and…

Apax Funds, a London-based investment firm, said it reached an agreement to buy Spanish API maker Invent Pharma.